BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30088402)

  • 41. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
    Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
    J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
    Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
    Am J Ophthalmol; 2014 Oct; 158(4):693-701.e2. PubMed ID: 25034116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short Communication: Increase of Sialylated N-Glycansin Eyes with Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy.
    Inafuku S; Noda K; Amano M; Nishimura S; Ishida S
    Curr Eye Res; 2016 May; 41(5):721-4. PubMed ID: 26177396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neovascular glaucoma: a retrospective review from a tertiary center in China.
    Liao N; Li C; Jiang H; Fang A; Zhou S; Wang Q
    BMC Ophthalmol; 2016 Jan; 16():14. PubMed ID: 26818828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neovascular glaucoma--prevention].
    Preda M; Davidescu L; Damian C; Irimia A; Sollosy M
    Oftalmologia; 2006; 50(2):108-14. PubMed ID: 16927768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
    Goto A; Inatani M; Inoue T; Awai-Kasaoka N; Takihara Y; Ito Y; Fukushima M; Tanihara H
    J Glaucoma; 2013 Sep; 22(7):572-6. PubMed ID: 22407392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
    Fong AW; Lee GA; O'Rourke P; Thomas R
    Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of neovascular glaucoma by anterior retinal cryotherapy and trabeculectomy].
    Ma L; Zhao B; Di Y
    Zhonghua Yan Ke Za Zhi; 1996 Mar; 32(2):118-22. PubMed ID: 9206228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma.
    Wittström E; Ponjavic V; Lövestam-Adrian M; Larsson J; Andréasson S
    Acta Ophthalmol; 2010 Feb; 88(1):86-90. PubMed ID: 19432876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications.
    Liu L; Xu Y; Huang Z; Wang X
    BMC Ophthalmol; 2016 May; 16():65. PubMed ID: 27230388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of neovascular glaucoma.
    Ajvazi H; Goranci I; Lutaj P
    Oftalmologia; 2013; 57(4):39-43. PubMed ID: 24844036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of intravitreal bevacizumab in neovascular glaucoma.
    Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pars plana modified Baerveldt implant versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma.
    Chalam KV; Gandham S; Gupta S; Tripathi BJ; Tripathi RC
    Ophthalmic Surg Lasers; 2002; 33(5):383-93. PubMed ID: 12358292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
    Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
    Acta Ophthalmol; 2010 Feb; 88(1):96-102. PubMed ID: 19775309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
    Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
    J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neovascular Glaucoma.
    Havens SJ; Gulati V
    Dev Ophthalmol; 2016; 55():196-204. PubMed ID: 26501989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
    Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trend of Neovascular Glaucoma in Taiwan: A 15-year Nationwide Population-based Cohort Study.
    Lin PA; Lee CY; Huang FC; Huang JY; Hung JH; Yang SF
    Ophthalmic Epidemiol; 2020 Oct; 27(5):390-398. PubMed ID: 32326791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia.
    Al-Bahlal A; Khandekar R; Al Rubaie K; Alzahim T; Edward DP; Kozak I
    Indian J Ophthalmol; 2017 Oct; 65(10):969-973. PubMed ID: 29044062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.